已收盤 07-31 16:00:00 美东时间
-1.510
-7.30%
JP Morgan analyst James Kirby maintains Columbus McKinnon (NASDAQ:CMCO) with a Overweight and raises the price target from $25 to $29.
今天 01:22
科技巨头资本开支“修复”AI信仰!铠侠ADR暴涨31%;微软财报凸显人工智能用电需求,燃料电池能源飙升30%;MKTX升逾29%,获纽交所母公司洲际交易所溢价收购>>
07-31 19:06
Columbus McKinnon (NASDAQ:CMCO) raises FY2027 Adj EPS guidance from $1.70-$1.90 to $1.90-$2.10 vs $1.75 analyst estimate. Raises FY2027 sales outlook from $2.050 billion-$2.120 billion to $2.090 billion-$2.150 billion vs $2.092 billion estimate.
07-30 18:41
Columbus McKinnon (NASDAQ:CMCO) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.27 by 125.93 percent. This is a 22 percent increase over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $531.461 million...
07-30 18:33
Columbus McKinnon (CMCO) declares $0.07/share quarterly dividend, in line with previous. Forward yield 1.95% Payable Aug. 17; for shareholders of record Aug. 7; ex-div Aug. 7. See CMCO Dividend Scorec...
07-21 04:32
Columbus McKinnon Corporation (Nasdaq: CMCO) ("Columbus McKinnon" or the "Company"), a leading designer, manufacturer and marketer of intelligent motion solutions for material handling, today announced the appointment of John R. Linker as the Company's new Executive Vice President of Finance and Chi...
07-02 04:08
John R. Linker Appointed Chief Financial Officer Company Reaffirms Fiscal Year 2027 Guidance CHARLOTTE, N.C., July 1, 2026 /PRNewswire/ -- Columbus McKinnon Corporation (Nasdaq: CMCO) ("Colu...
07-02 04:05
今日重点评级关注:HC Wainwright & Co.:维持Elicio Therapeutics"买入"评级,目标价从17美元升至23美元;Leerink Partners:维持SAB Biotherapeutics"跑赢大市"评级,目标价从7美元升至12美元
06-16 11:34
DA Davidson analyst Matt Summerville maintains Columbus McKinnon (NASDAQ:CMCO) with a Neutral and lowers the price target from $20 to $17.
06-16 02:39
Columbus McKinnon (NASDAQ:CMCO) reported fourth-quarter financial results on Th...
06-04 23:14